Description
Bemethyl (Bemetil) research nootropic
Bemethyl is a synthetic benzimidazole derivative developed in the Soviet Union and classed as an actoprotector.
Product details
| Compound | Bemethyl (bemetil) |
|---|---|
| Class | Benzimidazole derivative (actoprotector) |
| Form | Powder; Capsules |
| Strength | 10g; 250mg per capsule/30ct/7.5g |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Protein synthesis research: RNA and protein expression.
- Hypoxia models: antihypoxic research.
- Comparative pharmacology: actoprotectors.
Research interest does not establish a proven effect in humans.
Regulatory status
Bemethyl is registered in Russia but is not approved by the FDA or EMA. The material sold here is a research chemical only. It is monitored by WADA.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Independent literature: search PubMed for published studies.
Related research products
Pregnenolone · Theacrine · Phenylpiracetam Carphedon · All nootropic powders
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.